EVH
Evolent Health, Inc. Industrials Services-Management Services Russell 3000
$4.30Close
$505.7MMarket cap
$2.17 – $6.7252-week range
Nov 5, 2026Next report · before the open
Highlights
Strengths
- Volume drying up last 10 days 32% under the 50-day average
Cautions
- Trend not confirmed 7 of 8 conditions · over 25% off the high
- Far from its high 36% below its 52-week high
- Results soon Nov 5, 2026, in 4 days
- Financial distress Altman Z″ in the distress zone
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
36%
1wk
down 10.4%
price change
1mo
up 23.2%
price change
12-month return
down 35%
market up 11% ·
its own down 50%
F-score
4 / 9
Weak
Altman Z″
-3.00
Elevated risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
1.2×
price / book
Earnings yield
down 31.0%
EBIT / enterprise value
Cheaper than
57%
of the market · around average
Revenue growth
down 27%
year on year
EPS growth
—
latest quarter
Sales growth
up 47%
latest quarter · +44 pts
ROE
down 82%
return on equity
Free cash margin
up 2%
$38.8M FCF
D/E
2.34
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Piotroski tests
- not yet profitable on its assets
- profitability slipped from last year
- took on more long-term debt
- issued more shares
- assets working less efficiently
- generating cash from operations
- profits backed by cash
- short-term liquidity improved
- gross margin widened
Repair signals
- Gross margin 14.4% → 21.3%
Trade setup
ATR%
6.2%
$0.26 a day · 2×ATR $3.77
RS
73 / 99
vs the universe
Trend
7 / 8
over 25% off the high
Relative volume
0.5×
vs 50-day average
Up/down volume
0.89
50 sessions
Implied move
—
no option chain · report Nov 5, 2026
Trend template · 7 of 8
- Within 25% of the 52-week high: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
- Revenue shrinking Revenue fell 26.6% over the year, from $2.6B to $1.9B.
Last reported
Aug 6, 2026
Last shock
Jul 23, 2026-17% in one session4.2× volumeno filing matched-7% since
Financials
- Gross 21%
- Net -31%
- Free cash 2%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $924.6M | $908.0M | $1.4B | $2.0B | $2.6B | $1.9B |
| Gross margin | — | 28% | 23% | 23% | 14% | 21% |
| Operating income | -$262.8M | -$42.4M | $3.6M | -$71.2M | -$40.5M | -$410.1M |
| Net income | -$334.2M | -$37.6M | -$19.2M | -$142.3M | -$93.5M | -$579.4M |
| Net margin | -36% | -4% | -1% | -7% | -4% | -31% |
| Earnings per share | -$3.94 | -$0.44 | -$0.20 | -$1.28 | -$0.82 | -$5.07 |
| Free cash flow | -$16.2M | $38.7M | -$11.6M | $142.6M | $18.8M | $38.8M |
| Free cash margin | -2% | 4% | -1% | 7% | 1% | 2% |
| Cash | $319.0M | $266.3M | $188.2M | $192.8M | $104.2M | $151.9M |
| Long-term debt | $263.3M | $215.7M | $413.0M | $597.0M | $490.5M | $970.5M |
| Shareholders' equity | $619.6M | $693.6M | $859.4M | $1.1B | $1.0B | $415.2M |
| Shares outstanding | 85.89m | 90.76m | 101.50m | 115.42m | 116.58m | 117.60m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 6, 2026 | Quarterly ↗ | Jun 30, 2026 | 37d |
| May 7, 2026 | Quarterly ↗ | Mar 31, 2026 | 37d |
| Feb 25, 2026 | Annual ↗ | Dec 31, 2025 | 56d |
| Nov 7, 2025 | Quarterly ↗ | Sep 30, 2025 | 38d |
| Aug 11, 2025 | Quarterly ↗ | Jun 30, 2025 | 42d |
| May 9, 2025 | Quarterly ↗ | Mar 31, 2025 | 39d |
| Feb 21, 2025 | Annual ↗ | Dec 31, 2024 | 52d |
| Nov 8, 2024 | Quarterly ↗ | Sep 30, 2024 | 39d |
| Aug 9, 2024 | Quarterly ↗ | Jun 30, 2024 | 40d |
| May 10, 2024 | Quarterly ↗ | Mar 31, 2024 | 40d |
| Feb 23, 2024 | Annual ↗ | Dec 31, 2023 | 54d |
| Nov 2, 2023 | Quarterly ↗ | Sep 30, 2023 | 33d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 6, 2026 | Results ↗ |
| Jun 4, 2026 | Shareholder vote ↗ |
| May 7, 2026 | Results ↗ |
| Feb 24, 2026 | Results ↗ |
| Dec 8, 2025 | Other events ↗ |
| Dec 2, 2025 | Director or officer change · Regulation FD ↗ |
| Nov 6, 2025 | Results · Director or officer change ↗ |
| Sep 23, 2025 | Regulation FD · Other events ↗ |
| Aug 21, 2025 | Material agreement · New obligation · Unregistered share sale ↗ |
| Aug 19, 2025 | Other events ↗ |
| Aug 18, 2025 | Other events ↗ |
| Aug 7, 2025 | Results ↗ |